Download pdf - oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Transcript

Page 1: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 2: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 3: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 4: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 5: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 6: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 7: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 8: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 9: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 10: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Page 11: oversight.house.gov · 11/4/2015 · The pharma business model has long called ... that Valeant uses to mask its price increases and shift them to insurance companies. Valeant

Recommended

Valeant Pharmaceutical International, Inc. 2016 J.P ...ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceutical International, Inc. 2016 J.P ... Company’s

Valeant Pharmaceutical International, Inc. 2016 J.P ...ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceutical International, Inc. 2016 J.P ... Company’s Documents

FINAL Testimony - oversight.house.gov

FINAL Testimony - oversight.house.gov Documents

The New Valeant: Delivering on Our Commitmentsir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...The New Valeant: Delivering on Our Commitments ... after the date of this presentation

The New Valeant: Delivering on Our Commitmentsir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...The New Valeant: Delivering on Our Commitments ... after the date of this presentation Documents

Valeant Pharmaceuticals International, Inc./media/Files/V/Valeant-IR/... · 2015-12-09 · Valeant Pharmaceuticals International, Inc. Investor Conference Call October 26, 2015

Valeant Pharmaceuticals International, Inc./media/Files/V/Valeant-IR/... · 2015-12-09 · Valeant Pharmaceuticals International, Inc. Investor Conference Call October 26, 2015 Documents

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (the “Company”)ir.valeant.com/~/media/Files/V/Valeant-IR/documents/valeant... · i Incorporation number: C0977395 VALEANT PHARMACEUTICALS

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (the “Company”)ir.valeant.com/~/media/Files/V/Valeant-IR/documents/valeant... · i Incorporation number: C0977395 VALEANT PHARMACEUTICALS Documents

Valeant Pharmaceuticals International, Inc. 2016 Annual …/media/Files/V/Valeant-IR/...statements regarding expected future performance of Valeant Pharmaceuticals International, Inc

Valeant Pharmaceuticals International, Inc. 2016 Annual …/media/Files/V/Valeant-IR/...statements regarding expected future performance of Valeant Pharmaceuticals International, Inc Documents

Valeant Slides Documents

Valeant Pharmaceuticals International (VRX) Earnings ... · The following Valeant Pharmaceuticals International conference call took place ... , everyone. Welcome to Valeant's investor

Valeant Pharmaceuticals International (VRX) Earnings ... · The following Valeant Pharmaceuticals International conference call took place ... , everyone. Welcome to Valeant's investor Documents

Valeant May Lawsuit

Valeant May Lawsuit Documents

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and-presentations/q1-2016-earnings...Valeant Pharmaceuticals International, Inc. First

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and-presentations/q1-2016-earnings...Valeant Pharmaceuticals International, Inc. First Documents

Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan …/media/Files/V/Valeant-IR/... · 2016. 1. 13. · Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan Healthcare

Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan …/media/Files/V/Valeant-IR/... · 2016. 1. 13. · Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan Healthcare Documents

Transcript of Proceedings in Valeant Allergan

Transcript of Proceedings in Valeant Allergan Documents

SPONSORED BY VALEANT PHARMACEUTICALS NORTH AMERICA LLC ... · SPONSORED BY VALEANT PHARMACEUTICALS NORTH AMERICA LLC ADVANCES IN DERMATOLOGY ... Sponsored by Valeant Pharmaceuticals

SPONSORED BY VALEANT PHARMACEUTICALS NORTH AMERICA LLC ... · SPONSORED BY VALEANT PHARMACEUTICALS NORTH AMERICA LLC ADVANCES IN DERMATOLOGY ... Sponsored by Valeant Pharmaceuticals Documents

Case Study: Valeant - ValueWalk · 2020-05-23 · We began the year with a 20% weighting in Valeant Pharmaceuticals (NYSE:VRX). Valeant rose by more than 80% through the summer, driving

Case Study: Valeant - ValueWalk · 2020-05-23 · We began the year with a 20% weighting in Valeant Pharmaceuticals (NYSE:VRX). Valeant rose by more than 80% through the summer, driving Documents

VALEANT PHARMACEUTICALS INTERNATIONAL, INC.people.stern.nyu.edu/adamodar/pc/blog/Valeant10K2015.pdf · VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (Exact Name of Registrant as Specified

VALEANT PHARMACEUTICALS INTERNATIONAL, INC.people.stern.nyu.edu/adamodar/pc/blog/Valeant10K2015.pdf · VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (Exact Name of Registrant as Specified Documents

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...Valeant Pharmaceuticals International, Inc. Q2 2015 Financial Results July 23, 2015

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...Valeant Pharmaceuticals International, Inc. Q2 2015 Financial Results July 23, 2015 Documents

Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical

Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical Documents

Valeant Pharmaceuticals Correct Recent Misrepresentations

Valeant Pharmaceuticals Correct Recent Misrepresentations Investor Relations